Harrow Health

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$66,831
$49,257
$48,939
$34,587
Gross Profit
52,696
37,239
36,400
24,034
EBITDA
17,449
4,670
2,853
-4,970
EBIT
12,638
1,324
-347
-8,150
Net Income
6,777
-4,220
-6,473
-13,565
Net Change In Cash
66,831
49,257
48,939
34,587
Free Cash Flow
-55,339
2,428
-3,153
-4,738
Cash
47,247
72,601
70,968
68,538
Basic Shares
35,650
35,702
35,618
35,469

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$199,614,000,000
$130,193
$88,595
$72,476
Gross Profit
150,369,000,000
90,553
63,212
54,262
EBITDA
8,822,000,000
9,723
-3,203
-10,143
EBIT
8,821,985,463
-2,617
-6,868
-12,539
Net Income
-17,481
-24,411
-14,086
-18,007
Net Change In Cash
199,614,000,000
130,193
88,595
72,476
Cost of Revenue
54,103
37,866
Free Cash Flow
-60,876
-148,713
-6,068
-23,430
Cash
47,247
74,085
96,270
42,167
Basic Shares
35,650
32,616
27,460
26,757

Earnings Calls

Quarter EPS
2024-12-31
$0.40
2024-09-30
-$0.05
2024-06-30
-$0.18
2024-03-31
-$0.38